This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
While ECT entails electrically induced seizures, BrainsWay Deep TMS therapy stimulates brain regions using brief magnetic pulses at an amplitude similar to that used in MRI systems. ECT requires anesthesia and may entail severe side effects, including memory loss, while BrainsWay Deep TMS therapy does not involve anesthesia, has no effects on memory, and is generally well-tolerated.